The Abstract: October 11, 2021
October 11, 2021
$1 million gift furthers landmark study focused on reducing breast cancer disparities, barriers to high-quality care
October 5, 2021 Rich Preyer and Marilyn Jacobs Preyer have donated $1 million to support the latest phase of the Carolina Breast Cancer Study at the UNC Lineberger Comprehensive Cancer Center. Led by Dr. Melissa Troester, professor of epidemiology at the UNC Gillings School, the study investigates how the causes, treatments and long-term outcomes of breast cancer differ between Black women and white women.
Carolina research produces effective experimental pill to treat COVID-19
October 1, 2021 University of North Carolina at Chapel Hill research set the stage to seek emergency authorization of the first oral antiviral drug to treat COVID-19.
Timeline to eliminate cervical cancer varies widely based on wealth
September 29, 2021 Increasing rates of vaccination against human papillomavirus will lead to a near-elimination of cervical cancer in some communities by 2030, according to recent research published in Cancer Epidemiology, Biomarkers & Prevention by a research team that includes Gillings School alumnae and faculty members. However, these projections point to a stark truth: a 14-year delay in areas with higher rates of poverty.
NC Medicaid review suggests many infants with prenatal opioid exposure are born to those receiving treatment
September 9, 2021 A new study led by Dr. Anna Austin suggests that, among Medicaid patients in North Carolina, about half of infants with prenatal opioid exposure are born to people receiving medication for the treatment of opioid use disorder – and these babies are more likely to experience better outcomes after birth.
New study gives insight into how often COVID-19 spreads through households
August 30, 2021 The study reports on how frequently COVID-19 spreads to other people living in the same household as someone diagnosed with the illness. The researchers emphasize that having many people living in one household is a major factor in infection risk, which disproportionately affects communities of color.
Vaccinations can stop delta variant
August 27, 2021 With delta driving more than 85% of COVID-19 cases in the United States, vaccinations are the best path for ending the pandemic, says virologist David R. Martinez.
Two Gillings leaders advance research on innovative solutions to public health challenges
August 24, 2021 Drs. Mark Sobsey and Steven Meshnick were two early recipients of Gillings Innovation Lab awards that proposed public health improvements to global communities and provided instrumental mentorship to students and faculty at UNC and the Gillings School today.
Mother-infant hepatitis B treatment, prevention feasible in sub-Saharan Africa
August 20, 2021 A study in Lancet Global Health, co-authored by a UNC Gillings student, shows the feasibility and acceptance of hepatitis B virus testing, treatment and vaccination programs in the Democratic Republic of the Congo.